Navigation Links
Fundamentals of Fermentation: Techniques For Benchtop Fermentors


Part I - E. col

Prepared by the R & D Lab, New Brunswick Scientific Co., Inc.


The following document outlines step-by-step procedures for carrying out a benchtop fermentation, particularly when using an NBS fermentor. Provided in a question and answer format, this article covers such topics as what media formulation, tubing size, and concentration of various additives should be used, as well as the preparation, autoclaving and clean up procedures for the vessel and accessories. Unless otherwise indicated, our example refers to an E. coli fermentation in a benchtop BioFlo 3000 fermentor. However, in general, the information should be valid for any fermentation.


Question: What kind of MEDIA should be used, and does it differ from media used in shake flasks?

Answer: The media used in shake flasks does differ from the standard media used in a fermentation vessel. Shake flask media is generally of a much simpler composition. LB Broth (Difco catalog number 0446-17-3 ) and Tryptic Soy Broth (Difco catalog number 0370-07-5) are standard shake flask media.

An example of a more complex media used in a recombinant E. coli fermentation follows:

For fermentation, the glucose solution is usually sterilized in a separate flask. It is then added aseptically to the other (heat labile) components that can not be subjected to autoclaving, such as Ampicillin and the trace metal solution. These are prepared in advance by sterile filtration so that they are available as stock solutions. The magnesium sulfate is sometimes sterilized separately. Most materials are available from a variety of vendors. Note that Sigma and Difco are often the best sources for the more unusual biologic
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
2. P. pastoris Fermentation using a BioFlo 110 Benchtop Fermentor
3. CHO Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor
4. Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor
5. Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor
6. High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation
Post Your Comments:
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... GenomeDx Biosciences today announced that a new ... genomic test for prostate cancer, was able to predict ... radical prostatectomy without adjuvant therapy. Although rapid metastasis in ... tumor genomics to identify these men who have a ... advance. The study has been published online by ...
(Date:12/22/2014)... Chicago, Illinois (PRWEB) December 22, 2014 ... representing tenants and occupiers of commercial real estate, has ... two new offices in Perth and Brisbane, Western Australia, ... board of directors. , ITRA Global / ACORPP ... and totally independent consultancy company providing property services to ...
Breaking Biology Technology:Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... , , SOUTH SAN ... SNSS ) reported today that it received a letter, dated September ... NASDAQ Stock Market notifying Sunesis that it does not comply with ... NASDAQ Capital Market set forth in NASDAQ Listing Rule 5550(a)(2). The ...
... , SAN DIEGO, Sept. 18, 2009 ... today that the company is scheduled to present at the UBS ... Eastern Time (12:30 p.m. Pacific Time) at the Grand Hyatt Hotel ... Officer, is scheduled to provide an overview of the company, including ...
... PRINCETON, N.J., Sept. 18 Covance Inc. (NYSE: ... Global Life Sciences Conference on Monday, September 21, 2009 at 10:00 ... presentation at www.covance.com . In order to ... early. , , Covance, with headquarters in Princeton, ...
Cached Biology Technology:Sunesis Pharmaceuticals Receives NASDAQ Notification 2Sunesis Pharmaceuticals Receives NASDAQ Notification 3Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 3
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... hadrosaur (duck-billed) dinosaur the oldest duck-billed dinosaur known ... who expect the discovery to shed new light on ... gagslarsoni , the name given to the new dinosaur, ... to later duck-billed relatives. Acristavus means "non-crested ...
... PASADENA, Calif.Artificial intelligence has been the inspiration for countless ... countless scientists and engineers. Researchers at the California Institute ... toward creating artificial intelligencenot in a robot or a ... are the first to have made an artificial neural ...
... SALT LAKE CITY A team of researchers from the ... mouse model of focal dermal hypoplasia, a rare human birth ... This animal model not only provides insight into studying the ... novel way to study a signaling pathway that is crucial ...
Cached Biology News:New duck-billed dinosaur gives scientists clues to evolution of head ornamentation and provinciality 2Caltech researchers create the first artificial neural network out of DNA 2Caltech researchers create the first artificial neural network out of DNA 3Caltech researchers create the first artificial neural network out of DNA 4Animal model sheds light on rare genetic disorder, signaling pathway 2
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
prototype Nco I...
Provides continuous mixing action. For use with tubes, vials, and other containers...
Based on Silica membrane matrix beads. The kit is designed for the purification of DNA (20 bp - 100 bp) from TAE/TBE agarose gels. Run time is approximately 45 minutes....
Biology Products: